Early Use of Antiretrovirals May Reduce HIV Transmission

Norman, Kayda
June 2011
Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p17
Academic Journal
The article discusses the findings of a study on a clinical trial known as the HPTN 052 in relation to the early use of oral antiretroviral therapy (ART). It states that the early use of ART may reduce the likelihood that a person with human immunodeficiency virus (HIV) will pass the virus to their sexual partners. Furthermore, the article states that the clinical trial was conducted by the HIV Prevention Trials Network.


Related Articles

  • Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children. Resino, Salvador; Larrú, Beatriz; Bellón, Jose Ma; Resino, Rosa; de José, Isabel; Navarro, Marisa; Léon, Juan Antonio; Ramos, José Tomás; Mellado, Ma.José; Muñoz-Fernández, Ma Ángeles // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p107 

    Background: Antiretroviral treatment (ART) in children has special features and consequently, results obtained from clinical trials with antiretroviral drugs in adults may not be representative of children. Nelfinavir (NFV) is an HIV-1 Protease Inhibitor (PI) which has become as one of the first...

  • Effectiveness of Pediatric Antiretroviral Therapy in Resource-Limited Settings: A Systematic Review and Meta-analysis. Ciaranello, Andrea L.; Yuchiao Chang; Margulis, Andrea V.; Bernstein, Adam; Bassett, Ingrid V.; Losina, Elena; Walensky, Rochelle P. // Clinical Infectious Diseases;12/15/2009, Vol. 49 Issue 12, p1915 

    Background. Responses to antiretroviral therapy (ART) among human immunodeficiency virus (HIV)-infected children in resource-limited settings have recently been reported, but outcomes vary. We sought to derive pooled estimates of the 12-month rate of virologic suppression (HIV RNA, Δ400...

  • Antiretroviral Prescribing Patterns in Treatment-Naïve Patients in the United States. McKinnell, James A.; Willig, James H.; Westfall, Andrew O.; Nevin, Christa; Allison, Jeroan J.; Raper, James L.; Mugavero, Michael J.; Saag, Michael S. // AIDS Patient Care & STDs;Feb2010, Vol. 24 Issue 2, p79 

    Numerous antiretroviral therapy (ART) regimens are recommended for first-line and subsequent HIV care, but regimen selection for clinical use may not represent the full range of options. We hypothesized that despite an increase in available antiretrovirals, clinical trial data on regimen...

  • Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure. Paredes, Roger; Lalama, Christina M.; Ribaudo, Heather J.; Schackman, Bruce R.; Shikuma, Cecilia; Giguel, Francoise; Meyer III, William A.; Johnson, Victoria A.; Fiscus, Susan A.; D'Aquila, Richard T.; Gulick, Roy M.; Kuritzkes, Daniel R. // Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p662 

    Background. The clinical relevance of detecting minority drug-resistant human immunodeficiency virus type 1 (HIV-1) variants is uncertain. Methods. To determine the effect of pre-existing minority nonnucleoside reverse-transcriptase inhibitor (NNRTI)-resistant variants on the risk of virologic...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • Treatment Strategies for HIV-Infected Patients with Tuberculosis: Ongoing and Planned Clinical Trials. François-Xavier Blanc; Havlir, Diane V.; Onyebujoh, Philip C.; Sok Thim; Goldfeld, Anne E.; Delfraissy, Jean-François // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS46 

    Currently, there are limited data to guide the management of highly active antiretroviral therapy (HAART) for human immunodeficiency virus type 1 (HIV-1)-infected patients with active tuberculosis (TB), the leading cause of death among individuals with acquired immunodeficiency syndrome (AIDS)...

  • Prevalence and factors associated with idiopathic hypercalciuria in HIV patients on combination antiretroviral therapy. Pocaterra, D.; Carenzi, L.; Ricci, E.; Minisci, D.; Schiavini, M.; Gervasoni, C.; Meraviglia, P.; Bevilacqua, M.; Rizzardini, G.; Bonfanti, P. // International Journal of STD & AIDS;Dec2010, Vol. 21 Issue 12, p829 

    Idiopathic hypercalciuria may lead to bone loss via three pathogenic mechanisms described in HIV-negative patients: intestinal hyperabsorption, kidney loss and bone hyperabsorption. We conducted a cross-sectional study in a cohort of 217 HIV-positive antiretroviral-experienced patients,...

  • Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Vriesendorp, Reinout; Cohen, Adam; Kristanto, Paulus; Vrijens, Bernard; Rakesh, Pande; Anand, Bene; Iwebor, Henry Uchechukwaka; Stiekema, Jacobus // European Journal of Clinical Pharmacology;Dec2007, Vol. 63 Issue 12, p1115 

    This pilot study was designed to evaluate the feasibility and benefits of electronic adherence monitoring of antiretroviral medications in HIV patients who recently started Highly Active Anti Retroviral Therapy (HAART) in Francistown, Botswana and to compare this with self-reporting. Dosing...

  • Real Life HAART Efficacy in Chronically HIV-1 Infected Children 15-Year Follow-Up. Monpoux, Fabrice; Rubio, Amandine; Sakarovitch, Charlotte; Fontas, Eric; Cottalorda-Dufayard, Jacqueline; Pradier, Christian // Journal of AIDS & Clinical Research;2012, Vol. 3 Issue 8, Special section p1 

    Background: It is now widely accepted that the antiretroviral first line-treatment basis in HIV-1 infected children is a combination of 2 nucleoside reverse transcriptase inhibitors and 1 protease inhibitor or 1 non NRTI. However, after few months or years, some patients presented with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics